Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 7Not yet recruiting 3Unknown 2Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Squamous Cell 1Neoplasms 1Lung Neoplasms 1Leukemia 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Advanced Solid Malignancies 1Advance Solid Tumors 1

Interventions

Cisplatin 3pembrolizumab 2Etoposide 2Docetaxel 2Carboplatin 2durvalumab 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radionuclide Imaging 1Radiation 1Prednisone 1Positron-Emission Tomography 1Platinum 1Paclitaxel 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Injections 1Exercise Therapy 1Erlotinib Hydrochloride 1Eflornithine 1Clinical Protocols 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Lung Neoplasms × Injections × Clear all
NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Cancer Research UK

Phase 1/2 Suspended
15 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡